We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

FTSE 100 bargains! 3 I’d buy in my ISA

I think we are seeing a great opportunity in the FTSE 100, and I’d put these three tempting investments in my Stocks and Shares ISA.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve been searching the FTSE 100 index for bargains, armed with my refreshed Stocks and Shares ISA allowance of £20,000.

I see two types of potential bargains in the current crisis. Firstly, there are those companies with operations largely unaffected by the economic shutdown. Sometimes such defensive firms have seen their share prices marked down by the market regardless.

XXX

Secondly, there are those companies that have seen their businesses greatly affected. Those stocks have fallen a long way. But I reckon there are decent opportunities among both types of share.

Pharmaceuticals

GlaxoSmithKline (LSE: GSK) strikes me as a good example of a firm operating in a defensive sector that’s likely to be less affected by the crisis.

On Tuesday, the company released an update describing a proposed collaboration with Sanofi to fight Covid-19.” The idea is the two firms will combine their “innovative” technologies to develop an “adjuvanted” vaccine for the disease. 

They expect their candidate vaccine to enter clinical trials in the second half of 2020. If it works, the vaccine will likely be available for use around a year later

Meanwhile, it’s hard for me to imagine the demand for GlaxoSmithKline’s medicines and treatments drying up. My guess is that people will keep using their medication regardless of the pandemic. Indeed, the company has a decent multi-year record of steady and rising cash flow, which looks set to continue.

I see the recent weakness in the share price as an opportunity to pick up some of the stock on better terms.

Plumbing and heating products

Plumbing and heating products supplier Ferguson (LSE: FERG) updated the market on 17 March with its half-year results report. The company said then that it was too early to understand how the unfolding coronavirus crisis would affect trading.

But the stock market has made its own judgement. At 5,188p, the share price is more than 30% down from the level it achieved in mid-February. And that’s after bouncing back a fair bit during March.

I’m optimistic about Ferguson’s business. After the recession following the credit crunch and financial crisis just over a decade ago, the company’s operations recovered well and expansion continued. I think the firm serves a resilient sector and is doing a good job of consolidating a fragmented industry.

In the report, the directors expressed an optimistic outlook for the long-term success of the company. I think the stock could make a decent vehicle for riding the recovery after this crisis, just as it did after the last one.

Finally, I promised three FTSE 100 bargains in this article’s headline. And my third choice is the index itself. Because the FTSE 100 is packed with the shares of cyclical companies, I reckon it has good bounce-back potential. So I reckon a FTSE 100 index tracker fund is an attractive proposition right now.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »